NEW YORK (GenomeWeb News) – Co-Diagnostics said recently that certain real-time PCR technology has been transferred to the company from DNA Logix.

DNA Logix transferred four patents and applications pursuant to a purchase agreement between the two firms. Under the terms of the agreement, Co-Diagnostics, based in Salt Lake City, exercised its option to purchase the technology related to real-time PCR diagnostics testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.